UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 11, 2008
Medical Nutrition USA, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 0-18349 | 11-3686984 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
10 West Forest Avenue Englewood, New Jersey | 07631 | ||
(Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area code (201) 569-1188
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Form 8-K, Current Report
Medical Nutrition USA, Inc.
Commission File No. 000-18349
Item 2.02. Results of Operations and Financial Condition.
On June 11, 2008, Medical Nutrition USA, Inc. released earnings for its first quarter ended April 30, 2008 and held an investor conference call on June 12, 2008 to discuss such release. A copy of the earnings release is attached hereto as Exhibit 99.1. A copy of the conference call script is attached hereto as Exhibit 99.2.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits
(c) | Exhibits. | ||
Exhibit | Description | ||
99.1 | Earnings press release dated June 11, 2008. | ||
99.2 | Conference call script dated June 12, 2008. |
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: June 13, 2008
Medical Nutrition USA, Inc. | ||
---|---|---|
By: | /s/ Alan Levy | |
Name: Alan Levy Title: Chief Financial Officer |
-3-
EXHIBIT INDEX
Exhibit | Description | ||
99.1 | Earnings press release dated June 11, 2008. | ||
99.2 | Conference call script dated June 12, 2008. |
-4-